Company Overview
Snapshot
Founded in April 2015 by Chen Nachum, Livia operates with 1–10 employees. The company has secured funding across five rounds, with its most recent funding event occurring in March 2026.
Business overview
Livia, operating under iPulse Medical, is a fem-tech brand specializing in drug-free solutions for menstrual pain relief. The company's core product is a wearable medical device that utilizes patented SmartWave™ Pain-Blocking Technology. This technology delivers gentle electric micro-pulses to activate the body’s natural pain-blocking mechanisms, providing rapid relief. Clinically proven and approved by regulatory bodies such as the FDA, CE, and Health Canada, Livia offers a portable, discreet, and reusable alternative to traditional pain medication, aiming to eliminate drug-related side effects or tolerance buildup. Livia serves the global consumer market within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Therapeutics for women's health.
Strategic signal
In March 2026, Livia secured equity crowdfunding, indicating continued investor confidence and market interest in its drug-free menstrual pain relief solution. This recent funding suggests the company is actively pursuing growth and expanding its reach, reinforcing its position in the fem-tech and digital therapeutics market.
Log in to access full profile ›Company Intelligence Q&A
- What is Livia's core product?
- Livia's core product is a wearable medical device that uses patented SmartWave™ Pain-Blocking Technology to provide drug-free menstrual pain relief by activating the body’s natural pain-blocking mechanisms.
- When was Livia founded and by whom?
- Livia was founded in April 2015 by Chen Nachum.
- Has Livia received regulatory approvals for its device?
- Yes, Livia's device is clinically proven and has received approvals from the FDA, CE, and Health Canada.
- What is the primary sector Livia operates in?
- Livia operates primarily in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Digital Therapeutics.